• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Johnson & Johnson launches Vision Made Possible to prompt discussions on eye health

News
Article

The effort will capture the real-life stories of patients and eye care professionals around the world.

A group of happy people. (Image Credit: AdobeStock/Nicholas Felix/peopleimages.com)

(Image Credit: AdobeStock/Nicholas Felix/peopleimages.com)

Johnson & Johnson has announced the launch of Vision Made Possible, which “aims to provide greater awareness of eye health from childhood myopia to presbyopia and cataracts.”

In an effort to raise awareness about the importance of eye health across all ages and stages of vision, Johnson & Johnson has partnered with Kate T Parker, a professional photographer and director, and New York Times best-selling author, to capture the real-life stories of patients and eye care professionals around the world.1

“I know the importance of early intervention for healthy vision on a personal level because I’ve navigated eye health issues firsthand and so has my family, so the opportunity to work on this project is so important to me,” said Parker, in a press release from the company. “The opportunity to amplify these stories and capture the power, humanity, and authenticity of how healthier sight has truly transformed these patients’ lives is so rewarding.”

According to a press release from Johnson & Johnson, more than 2 billion people around the world suffer from visual impairment, yet 1 billion of these instances could have been prevented or have yet to be addressed. While the number of people experiencing blindness and visual impairment globally is expected to double by 2030 unless corrective measures are taken.1

Vision Made Possible will explore personal stories of patients around the world and eye care professionals across various eye diseases including myopia, presbyopia, cataracts, and others, to highlight how their life improved with better vision and educate others on the importance of comprehensive eye care.

“Sight is our most important sense, and Johnson & Johnson Vision is committed to serving patients’ eye health throughout every stage of their lives,” said Peter Menziuso, Company Group Chairman at Johnson & Johnson Vision. “Vision Made Possible represents our aspiration to elevate the importance of global eye health combining innovation with education and awareness. It starts with an annual eye exam; it continues through healthy lifelong habits. Vision Made Possible is about driving all this and more.”

One individual’s story Vision Made Possible tells is Jim M. who has suffered from severe nearsightedness from an early age. Around the age of 60, Jim experienced a “frightening moment” where he couldn’t see while driving because the signs were blurry. Jim signified this was a wake-up call, and he got in contact with an eye care professional immediately. Jim was diagnosed with cataracts and opted for transformative surgery that “changed his life and restored his independence and freedom.”

Other real stories of individuals around the globe, captured by Kate T Parker, will be available across a variety of channels, with some available online now.

References:
  1. Johnson & Johnson Vision Teams Up with Photographer and New York Times Best-Selling Author, Kate T. Parker to Ignite Conversations About Importance of Eye Health. Press Release. Released September 26, 2023. Accessed September 26, 2023. https://www.jjvision.com/press-release/johnson-johnson-vision-teams-photographer-and-new-york-times-best-selling-author-kate
Related Videos
Video 1 - "Challenging the Definition of Dry Eye- Interpreting Diagnostic Tests"
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.